Identification of Nephrogenic Therapeutic Biomarkers of Wilms Tumor Using Machine Learning

Figure 7

Methylation comparison between the high- and low-risk groups and correlation analysis of the mRNA expression and methylation level. (a–h) Comparison between the high- and low-risk groups regarding the methylation of AQP2, CLDN19, DEFB1, HMGCS2, KCNJ1, NAT8, TMPRSS2, and UMOD. (i–p) Correlation analysis of the mRNA expression and methylation level of AQP2, CLDN19, DEFB1, HMGCS2, KCNJ1, NAT8, TMPRSS2, and UMOD; Spearman correlation.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)